Do not administer IV. Does not protect against diseases caused by other types of
H. influenzae nor against meningitis caused by other organisms. Hypersensitivity to neomycin & polymyxin. Postpone vaccination in patients w/ acute severe febrile illness. Thrombocytopenia or bleeding disorders. Syncope as psychogenic response to the needle inj. Subsequent dose of vaccine should be carefully considered if any of the following occur: Rectal temp ≥40°C w/in 48 hr of unidentifiable cause; collapse or shock-like state (hypotonic-hyporesponsive episode) w/in 48 hr of vaccination; persistent, inconsolable crying lasting ≥3 hr w/in 48 hr of vaccination; convulsion w/ or w/o fever w/in 3 days of vaccination. Progressive neurological disorders in childn including infantile spasms, uncontrolled epilepsy or progressive encephalopathy. Consider risk of apnea & resp monitoring for 48-72 hr in very premature infants (≤28 wk of gestation) & those w/ history of resp immaturity. Not recommended in adults, adolescent or childn >5 yr. Pregnancy & lactation.